Cidara Therapeutics (CDTX) Update / Briefing June 23, 2025 08:30 AM ET Speaker0 Greetings. Welcome to Sadara Therapeutics announces positive top line results from its phase two b NAVIGATE trial evaluating CD388, a nonvaccine preventative of seasonal influenza. At this time, all participants will be in listen only mode. A question and answer session will follow today's formal presentation. Reminder, this conference is being recorded. At this time, I'll hand the conference over to Brian Ritchie with Investor ...